Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685451 · ClinicalTrials.gov registry record · Phase 1
Cognitive Therapy for PTSD in Addiction Treatment
A Phase 1 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 49
- Enrollment target
- 3
- Study locations
NCT00685451 is a Phase 1 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 49 participants, below the 155-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (68% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT00685451, a Phase 1 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 49 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this phase of the study is to assess the feasibility of a cognitive behavioral therapy for post-traumatic stress disorder (PTSD) in persons receiving outpatient services at an addiction treatment program. The next phase of the study will be a more rigorous investigation of the efficacy of the PTSD therapy within addiction treatment settings.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
Study Locations (3)
New Hampshire
- Fresh Start at Concord Hospital - Concord
- Farnum Center - Manchester
Vermont
- Quitting Time - Wilder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00685451
The ClinicalTrials.gov registry entry for NCT00685451 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (68% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT00685451 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New Hampshire, Vermont.
Frequently Asked Questions
What is clinical trial NCT00685451 about?
NCT00685451 is a clinical study titled "Cognitive Therapy for PTSD in Addiction Treatment". The purpose of this phase of the study is to assess the feasibility of a cognitive behavioral therapy for post-traumatic stress disorder (PTSD) in persons receiving outpatient services at an addiction treatment program. The next phase of the study will be a more rigorous investigation of the efficac...
What is the current status of trial NCT00685451?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 49 participants. The study started on 2004-11. Estimated completion is 2006-11.
What conditions does trial NCT00685451 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic, Substance-Related Disorders.
What interventions are being tested in trial NCT00685451?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00685451?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00685451 being conducted?
This trial has 3 study locations across New Hampshire, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy
COMPLETED · Phase 1
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Overcontrol and Suicide in PTSD
RECRUITING
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
Explore more on PlainTrial
Stress Disorders, Post-Traumatic
All registered trials for this condition
Substance-Related Disorders
All registered trials for this condition
New Hampshire
All trials with a study site in New Hampshire
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.